000			02073 a2200625 4500
005			20250513115222.0
264		0	_c19970616
008			199706s 0 0 eng d
022			_a0014-2999
024	7		_a10.1016/s0014-2999(97)00045-9 _2doi
040			_aNLM _beng _cNLM
100	1		_aBaron, B M
245	0	0	_aPharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. _h[electronic resource]
260			_bEuropean journal of pharmacology _cApr 1997
300			_a181-92 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAnti-Anxiety Agents _xpharmacology
650	0	4	_aAnticonvulsants _xpharmacology
650	0	4	_aCalcium Channels _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aCerebellum _xmetabolism
650	0	4	_aCyclic GMP _xmetabolism
650	0	4	_aExcitatory Amino Acid Agonists _xpharmacology
650	0	4	_aExcitatory Amino Acid Antagonists _xmetabolism
650	0	4	_aIndoles _xmetabolism
650	0	4	_aLigands
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred DBA
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aN-Methylaspartate _xpharmacology
650	0	4	_aPhencyclidine _xanalogs & derivatives
650	0	4	_aRats
650	0	4	_aRats, Inbred F344
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Glycine _xantagonists & inhibitors
650	0	4	_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors
650	0	4	_aSodium Channels _xdrug effects
700	1		_aHarrison, B L
700	1		_aKehne, J H
700	1		_aSchmidt, C J
700	1		_avan Giersbergen, P L
700	1		_aWhite, H S
700	1		_aSiegel, B W
700	1		_aSenyah, Y
700	1		_aMcCloskey, T C
700	1		_aFadayel, G M
700	1		_aTaylor, V L
700	1		_aMurawsky, M K
700	1		_aNyce, P
700	1		_aSalituro, F G
773	0		_tEuropean journal of pharmacology _gvol. 323 _gno. 2-3 _gp. 181-92
856	4	0	_uhttps://doi.org/10.1016/s0014-2999(97)00045-9 _zAvailable from publisher's website
999			_c9110357 _d9110357